MENU

Fox Chase Cancer Center News

April 16, 2021

Two New Studies Outline Treatment Decisions for Patients With Kidney Masses

PHILADELPHIA (April 16, 2021)—Alexander Kutikov, MD, FACS, chief of the Division of Urology and Urologic Oncology at Fox Chase Cancer Center, co-authored two publications examining important treatment decisions in kidney cancer and illustrating the role of minimally invasive partial nephrectomy—partial removal of the kidney—in the treatment of renal masses, which are abnormal growths on the kidney.

April 16, 2021

Fox Chase Cancer Center’s Colleen Tetzlaff Recognized With Inaugural Sharon Schwartz Award

PHILADELPHIA (April 16, 2021)—Colleen H. Tetzlaff, MHS, PA-C, advanced practice clinician in the Department of Hematology/Oncology at Fox Chase Cancer Center, has been recognized as the recipient of the first-ever Sharon Schwartz Award, which is presented by the Recognition and Development Model (RDM) Committee at Fox Chase.

April 14, 2021

Study Highlights Novel Approach to Promoting Cancer Cell Death

PHILADELPHIA (April 14, 2021) – In a study published today, researchers at Fox Chase Cancer Center announced that they have discovered a novel approach to triggering a type of cancer cell death called ferroptosis that could have therapeutic potential.

April 9, 2021

Research Comparing Radiation Therapies Show They Are Safe for Prostate Cancer Patients

PHILADELPHIA (April 9, 2021)— During a poster session at this year’s American Association for Cancer Research (AACR) Annual Meeting Part 1, researchers at Fox Chase Cancer Center will present findings from a recent study on predicting therapy response in locally advanced rectal cancer patients.

April 9, 2021

Fox Chase Researchers to Present Poster Session on Biomarkers in Rectal Cancer Patients at AACR Annual Meeting

PHILADELPHIA (April 9, 2021)— During a poster session at this year’s American Association for Cancer Research (AACR) Annual Meeting Part 1, researchers at Fox Chase Cancer Center will present findings from a recent study on predicting therapy response in locally advanced rectal cancer patients.

April 8, 2021

Researchers Say Postoperative Outcomes Following Various Types of Reconstructive Breast Surgery Show They Are Safe Options

PHILADELPHIA (April 8, 2021)—A study from researchers at Fox Chase Cancer Center has shown that while complication rates differ among methods of reconstructive breast surgery, both implants and autologous methods that use a patient’s own tissue are safe options.

April 7, 2021

Researchers Determine Factors That Indicate How Peritoneal Washings Help Predict Presence of Malignant Cells in Pancreatic Cancer Patients

PHILADELPHIA (April 7, 2021)—In a recent study, researchers at Fox Chase Cancer Center identified several factors that may accurately predict the presence of malignant cells in pancreatic cancer patients who undergo a peritoneal washing.

April 7, 2021

Fox Chase Awarded Grant to Help Fund Expansion of Tobacco Treatment Program

PHILADELPHIA (April 7, 2021)—Fox Chase Cancer Center was recently awarded Tobacco Treatment Program Supplements from the National Cancer Institute to support the expansion of current services for patients who use tobacco. 

Pages

Connect with Fox Chase